Gemtuzumab ozogamicin (solution), CAS 220578-59-6

Product Description: Gemtuzumab ozogamicin (solution) is an antibody-drug conjugate (ADC) consisting of a humanized immunoglobulin (IgG4) antibody directed against CD33 that is conjugated to the cytotoxic agent Calicheamicin (HY-19609). Calicheamicin is a cytotoxic antibiotic. Gemtuzumab ozogamicin can be used for the research of acute myeloid leukemia (AML)[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Yi Liu, et al. CD33-directed immunotherapy with third-generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33-edited acute myeloid leukemia and hematopoietic stem and progenitor cells. Int J Cancer. 2022 Apr 1;150(7):1141-1155./[2]Baron J, et al. Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia. Expert Rev Clin Pharmacol. 2018;11(6):549-559.

CAS Number: 220578-59-6

Molecular Weight: 151000 (average)

Research Area: Cancer

Target: Antibody-Drug Conjugates (ADCs);Apoptosis

• SKU: MEXHY-109539A-0
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-109539A-0
• Package Unit: Get quote
• Quantity Unit: STK